Abstract
To evaluate the impact of a recently developed, non-invasive risk score predictive for type 2 diabetes on the incidence and mortality of cardiovascular diseases and specific types of cancer. A total of 23,455 participants from the population-based European Prospective Investigation into Cancer and Nutrition (EPIC)–Potsdam study aged 35–65 years and free of diabetes and major chronic diseases at baseline (1994–1998) were followed through 2006 for incident myocardial infarction, stroke, types of cancer, and death. Risk score points were assigned to each participant based on age, waist circumference, height, physical activity, history of hypertension, smoking, alcohol consumption, and intake of red meat, whole-grain bread, and coffee. Hazard ratios (HRs) were estimated by Cox regression models. In age- and sex-adjusted analyses, participants with a high risk score (5-year probability to develop diabetes ≥ 10%) had significantly higher risks of myocardial infarction (HR 2.7, 95% CI 1.5–5.0) and stroke (1.9, 1.0–3.6), but not of colon, breast or prostate cancer incidence, than those with a low score (5-year probability < 1%). In addition, participants with a high risk score had considerably higher risks of cardiovascular (HR 4.6, 95% CI 2.3–9.4), cancer (1.7, 1.1–2.7), and total mortality (2.4, 1.8–3.4), the latter being equivalent to a difference in life expectancy of 13 years. These data indicate that a risk score predictive for type 2 diabetes is also related to elevated risks of myocardial infarction, stroke, and premature death in apparently healthy individuals and emphasize the need for early intervention in high-risk individuals.
Similar content being viewed by others
Abbreviations
- EPIC:
-
European Prospective Investigation into Cancer and Nutrition
- HR:
-
Hazard ratio
- ICD:
-
International classification of disease
References
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–57. doi:10.1016/S0140-6736(06)68770-9.
Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, Mohlig M, et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care. 2007;30(3):510–5. doi:10.2337/dc06-2089.
Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008;29(7):932–40. doi:10.1093/eurheartj/ehn018.
Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA. 2002;288(20):2569–78. doi:10.1001/jama.288.20.2569.
Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the atherosclerotic peripheral vascular disease interdisciplinary working group; cardiovascular nursing council; clinical cardiology council; nutrition, physical activity, and metabolism council; and the quality of care and outcomes research interdisciplinary working group: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37(6):1583–633.
Ding EL, Mozaffarian D. Optimal dietary habits for the prevention of stroke. Semin Neurol. 2006;26(1):11–23. doi:10.1055/s-2006-933305.
Martinez ME. Primary prevention of colorectal cancer: lifestyle, nutrition, exercise. Recent Results Cancer Res. 2005;166:177–211.
Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007;86(3):s836–42.
Kushi LH, Byers T, Doyle C, Bandera EV, McCullough M, McTiernan A, et al. American cancer society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2006;56(5):254–81. doi:10.3322/canjclin.56.5.254. quiz 313–314.
Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570–81. doi:10.1001/jama.287.19.2570.
Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005;97(22):1679–87.
Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr. 2007;86(3):s823–35.
Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 2005;28(9):2130–5. doi:10.2337/diacare.28.9.2130.
Boeing H, Korfmann A, Bergmann MM. Recruitment procedures of EPIC-Germany. European investigation into cancer and nutrition. Ann Nutr Metab. 1999;43(4):205–15. doi:10.1159/000012787.
Liese AD, Hense HW, Brenner H, Lowel H, Keil U. Assessing the impact of classical risk factors on myocardial infarction by rate advancement periods. Am J Epidemiol. 2000;152(9):884–8. doi:10.1093/aje/152.9.884.
Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995;51(2):524–32. doi:10.2307/2532940.
Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, et al. Identifying individuals at high risk for diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005;28(8):2013–8. doi:10.2337/diacare.28.8.2013.
Kanaya AM, Wassel Fyr CL, de Rekeneire N, Shorr RI, Schwartz AV, Goodpaster BH, et al. Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care. 2005;28(2):404–8. doi:10.2337/diacare.28.2.404.
Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D’Agostino RB Sr. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham offspring study. Arch Intern Med. 2007;167(10):1068–74. doi:10.1001/archinte.167.10.1068.
Stern M, Williams K, Eddy D, Kahn R. Validation of prediction of diabetes by the Archimedes model and comparison with other predicting models. Diabetes Care. 2008;31(8):1670–1. doi:10.2337/dc08-0521.
Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26(3):725–31. doi:10.2337/diacare.26.3.725.
Balkau B, Lange C, Fezeu L, Jean T, de Lauzon-Guillain B, Czernichow S, et al. Predicting diabetes–clinical, biological and genetic approaches: the D.E.S.I.R. Study. Diabetes Care. 2008.
Aekplakorn W, Bunnag P, Woodward M, Sritara P, Cheepudomwit S, Yamwong S, et al. A risk score for predicting incident diabetes in the Thai population. Diabetes Care. 2006;29(8):1872–7. doi:10.2337/dc05-2141.
Silventoinen K, Pankow J, Lindstrom J, Jousilahti P, Hu G, Tuomilehto J. The validity of the Finnish diabetes risk score for the prediction of the incidence of coronary heart disease and stroke, and total mortality. Eur J Cardiovasc Prev Rehabil. 2005;12(5):451–8. doi:10.1097/01.hjr.0000174793.31812.21.
Spijkerman A, Griffin S, Dekker J, Nijpels G, Wareham NJ. What is the risk of mortality for people who are screen positive in a diabetes screening programme but who do not have diabetes on biochemical testing? Diabetes screening programmes from a public health perspective. J Med Screen. 2002;9(4):187–90. doi:10.1136/jms.9.4.187.
Bonovas S, Filioussi K, Tsantes A. Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia. 2004;47(6):1071–8. doi:10.1007/s00125-004-1415-6.
Acknowledgments
We thank Ellen Kohlsdorf and Wolfgang Bernigau for data management and Wolfgang Fleischhauer for case ascertainment. The recruitment phase of the EPIC-Potsdam Study was supported by the Federal Ministry of Science, Germany (01 EA 9401) and the European Union (SOC 95201408 05F02). The follow-up of the EPIC-Potsdam Study was supported by the German Cancer Aid (70-2488-Ha I) and the European Community (SOC 98200769 05F02).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heidemann, C., Boeing, H., Pischon, T. et al. Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. Eur J Epidemiol 24, 281–288 (2009). https://doi.org/10.1007/s10654-009-9338-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-009-9338-7